EN DE

Molina Healthcare Inc (MOH) Fair Value & Analysis

Healthcare · US · Market cap $12.1B · ISIN US60855R1005

What is Molina Healthcare Inc really worth?

MH Molina Healthcare Inc logo Molina Healthcare Inc MOH · US
Price$202.91
Fair Value$199.31
Upside−1.8%
Quality53/100

A solid business, currently priced close to our fair value of $199.31.

Watch Molina Healthcare Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free

Risks

!Expensive Growth (revenue 5y +18.5 %/yr)
!Thin margins · 0.4% net margin
!Moderate debt · negative free cash flow
!Trails peers (1/13)
!Narrow moat 33/100
!Evidence only medium, so the estimate is less certain
!Weak on past: 18 out of 100
Evidence: Medium Range $149.48 – $249.14

Fair value as of: Sep 3, 2026

From 15 valuation models · updated yesterday

Share price +6.0% over the past month.

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

What matters now

  • The price sits close to our fair value, market and models broadly agree here, little valuation tension.
  • The price sits in the upper half of our model range, so the margin of safety is thin.
  • Read the verdict with care: some models are missing inputs, so the estimate scatters more than usual.

Price vs Fair Value (5 years)

$419.53 $122.65 Fair Value $199.31 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 3, 2026.

How to read this chart

60‑month range $122.65 – $419.53 · fair‑value band $149.48 – $249.14 · the $202.91 price screens above the $199.31 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 3, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Molina Healthcare Inc (MOH) currently trades at $202.91, while our model-based Fair Value estimate is $199.31, implying the stock looks roughly 1.8% fairly valued today. The Quality Score stands at 53/100 (solid quality), in the Healthcare sector. Bull case: the DCF Models group reads highest at a median of $351.01 per share, and 7 of the 15 models we run sit above the $202.91 price. Bear case: the Asset-Based group reads lowest at $52.33, and 8 of the 15 models stay below the price. Evidence for this calculation is medium.

Over the trailing twelve months, Molina Healthcare Inc generated revenue of $43.1B at a net margin of 0.4%. Revenue declined 4.3% year over year. It earns a return on equity of 4.5%. The balance sheet holds a net cash position of $298M. Fundamentals as of Sep 3, 2026

Our scenario range runs from $149.48 (bear case) to $249.14 (bull case); at $202.91, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 35% below its 52-week high and 68% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at −26% fair-value upside, at −2%, MOH screens cheaper than that median.

Fair Value models

This estimate rests on fiscal year 2025 figures, and about 8 months have passed since. In that time the company retained roughly $2.53 per share, which is 1.3 % of the fair value. The fair value deliberately does not add this in: the models value reported figures, not a projection.

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
EPV best evidence $130.63 $150.86 $168.56 74
Residual Income $71.60 $83.85 $168.77 72
Owner Earnings $170.00 $351.01 $710.83 71
All 15 models by family
DCF Models
Owner Earnings $170.00 $351.01 $710.83 71
Earnings-Based
Graham-Dodd $61.60 $386.57 $539.95 63
Lynch FV $111.42 $159.18 $206.93 61
PEG = 1.0 $111.42 $159.18 $206.93 57
EPV best evidence $130.63 $150.86 $168.56 74
Multiples
P/E Multiple $149.48 $199.31 $249.14 63
P/S Multiple $115.51 $154.01 $192.51 58
P/B Multiple $115.51 $154.01 $192.51 55
EV/EBIT $200.38 $264.09 $327.80 66
EV/EBITDA $205.95 $271.52 $337.08 67
EV/Revenue $145.66 $204.13 $262.59 54
Asset-Based
NCAV (Graham) $39.05 $52.33 $78.10 54
Economic Profit
Residual Income $71.60 $83.85 $168.77 72
ROIC Compounder $156.81 $224.31 $313.30 71
Growth Earnings
Growth-Adj P/E $162.33 $231.90 $301.46 67

Widest divergence: DCF Models ($351.01) versus Asset-Based ($52.33). Highest evidence: EPV (74).

Notify me when MOH reaches fair value

Put MOH on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Free, no payment details. Unsubscribe anytime in one click.

Key figures & financial health

P/E ratio 54.0
P/S ratio 0.56 P/E × margin
EPS (TTM) $3.76 price ÷ EPS = P/E 54.0
Net margin 1.0% FY2025
Return on equity 4.5% TTM
Return on assets (EBIT) 8.9% avg 5y
More key figures
Profitability
Operating margin 1.7% TTM
Growth
Revenue (TTM) $43.1B TTM
Revenue growth (YoY) −4.3% 3y avg +12.4%
EPS growth (YoY) −95.0%
Balance sheet & cash flow
Free cash flow −$636M FY2025
Net cash $298M FY2025

Figures from reported company fundamentals · as of Sep 3, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 53/100

Of which business quality 52 · Market factors (momentum, volatility) 56

Profitability 49
Margins and returns on capital today
Quality Growth 42
Are margins and returns improving?
Cashflow 12
Earnings quality: real cash, not paper profit
Fin. Strength 64
Balance sheet, leverage, solvency risk
Investment 68
Disciplined investing over empire-building
Low Volatility 46
Calm price path (market factor)
Momentum 62
Price trend over the last 3–12 months (market factor)
52W Momentum 58
Distance to the 52-week high (market factor)
Net Issuance 100
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.

About the company

Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates in four segments: Medicaid, Medicare, Marketplace, and Other.

Full company description

Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company was founded in 1980 and is headquartered in Long Beach, California.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Molina Healthcare Inc reported revenue of $45.4B in FY2025 versus $27.8B in FY2021, a compound +13.1%/yr. Reported net income was $472M in FY2025, compounding −8.0%/yr from FY2021.

Growth Quality 58/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Latest Revenue (FY 2025)
$45.4B
Latest YoY
+11.7%
Avg. revenue growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+12.4%
Avg. revenue growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+18.5%
Avg. revenue growth/yr (26Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+23.6%
Value creation/yr (5Y) Earnings growth per share (CAGR 5 years) plus dividend yield: value created per share and year.
−3.7% (−3.7 + 0.0)
Revenue +13.1%/yr
FY21 $27.8B
FY22 $32.0B
FY23 $34.1B
FY24 $40.7B
FY25 $45.4B
Net income −8.0%/yr
FY21 $659M
FY22 $792M
FY23 $1.1B
FY24 $1.2B
FY25 $472M

Watch MOH: get an alert when its fair value changes →

Share or link this analysis
𝕏 Post WhatsApp LinkedIn Reddit
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Molina Healthcare Inc Fair Value". https://www.fairvalue-calculator.com/stock/MOH

Recent news

External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.

Peer Group

Healthcare Plans · 15 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 53 · Bottom 25%
Fair Value upside −2% · Below median
Return on equity (TTM) 4% · Below median
Return on assets 2% · Below median
Net margin (TTM) 0% · Bottom 25%
Operating margin (TTM) 2% · Bottom 25%
Revenue growth −4% · Bottom 25%
Debt / equity 0.93× · Higher than 75% of peers

Valuation Multiples vs Healthcare Plans median · lower = cheaper

P/E (TTM) 54.0× · Pricier than 75% of peers
P/B 2.97× · Pricier than median
P/S (TTM) 0.28× · Cheaper than 75% of peers
EV/EBITDA 18.3× · Pricier than median
PEG 2.16× · Pricier than 75% of peers

Strength profile in five axes (Snowflake)

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE31 · sector 33
FUTURE0 · sector 23
PAST18 · sector 30
HEALTH54 · sector 65
DIVIDEND0 · sector 34

Insider activity: 40/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Healthcare Plans stocks, each showing price versus our Fair Value estimate (as of Sep 3, 2026).

Stock Price Fair Value vs Fair Value
UnitedHealth Group UNH $395.05 $292.06 −26%
CVS Health Corporation CVS $93.06 $42.25 −55%
Elevance Health, Inc ELV $399.14 $426.53 +7%
The Cigna Group CI $276.08 $495.42 +79%
Humana Inc HUM $385.54 $126.42 −67%
Centene Corporation CNC $64.75 $111.96 +73%
Oscar Health, Inc OSCR $30.93 $61.86 +100%
Alignment Healthcare, Inc ALHC $13.52 $2.37 −82%
Progyny, Inc PGNY $25.65 $16.44 −36%
Medi Assist Healthcare Services Limited MEDIASSIST ₹346.80 ₹226.12 −35%

Compare Molina Healthcare Inc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screener Filter by region, size and sector Compare tool Two stocks side by side Extrinsic Value Calculator (Options) Splits an option premium into intrinsic and extrinsic (time) value. Peter Lynch Fair Value Formula & Calculator Apply Peter Lynch's fair value formula in seconds: fair P/E ≈ earnings growth (+ dividend) - free, with formula and example.

Frequently asked questions

Is Molina Healthcare Inc (MOH) overvalued or undervalued?
As of Sep 3, 2026, our model estimates a fair value of $199.31 versus a price of $202.91, about −2% upside (fairly valued).
What is the fair value of MOH?
Our model-based fair value for Molina Healthcare Inc is $199.31 (as of Sep 3, 2026), built from audited fundamentals. The current price: $202.91.
What is the quality score of MOH?
Molina Healthcare Inc has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Molina Healthcare Inc (MOH)?
Molina Healthcare Inc reported trailing-twelve-month revenue of about $43.1B (latest available figure, as of Sep 3, 2026).
What is the net profit margin of MOH?
The net profit margin of Molina Healthcare Inc is about 0.4%, meaning it keeps roughly 0.4% of revenue as net income. Based on the latest reported figures.
Free · no account needed

Watch Molina Healthcare Inc in the live analysis

One click puts Molina Healthcare Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.